‹ Team › Management Team

Ethan Geier, PhD

Senior Director, Research and Development

Ethan brings bioinformatic expertise and insight into neurodegenerative disease pathobiology to support the Company’s biomarker development and biomarker analysis for clinical programs. Previously, he was head of bioinformatics at PrimeFour Therapeutics, and a staff scientist at the University of California, San Francisco Memory and Aging Center. He also was President and Co-founder of Apricity Therapeutics where he led and coordinated preclinical discovery and development.